Previous studies have shown that decreased GSN expression enhanced mesenchymal marker expression to promote cell migration, invasion, and metastasis in several types of cancers such as breast cancer, glioblastoma, and gastric cancer [29–31]. The gene discussed is GSN; the disease is gastric cancer.